To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CBX1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
294 supporting clones for gene CBX1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA154860 amygdala .a 1 to 542 10 to 553   tiling clone, capped   552/554
(99 %)
11 diff
(98.1 %id)
BG473070 eye, retinoblastoma .a 1 to 685 5 to 690   tiling clone,   606/705
(85 %)
24 diff
(96.6 %id)
BM721815 eye, fetal eye .a 18 to 439 1 to 422       422/422
(100 %)
1 diff
(99.8 %id)
BJ991840 hepatoblastoma .a 39 to 496 1 to 459       459/459
(100 %)
2 diff
(99.6 %id)
DA277578 corpus callosum .a 146 to 720 2 to 578   tiling clone, capped   577/577
(100 %)
2 diff
(99.7 %id)
BU740016 eye, fetal eye .a 1587 to 2156 588 to 19   tiling clone, AAA   570/570
(100 %)
0 diff
(100 %id)
BJ991841 hepatoblastoma .a 1621 to 2126 506 to 1       506/506
(100 %)
0 diff
(100 %id)
BC002821 Uterus, endometrium adenocarcinoma .b 1 to 1203 1217 to 10   tiling clone, available from MGC, AAA Submitted on the opposite strand 1208/1209
(99 %)
10 diff
(99.2 %id)
DW411461 Liver .b 117 to 428 329 to 18       312/329
(94 %)
0 diff
(100 %id)
DW412738 Liver .b 123 to 428 323 to 18   tiling clone,   306/323
(94 %)
0 diff
(100 %id)
BE394811 endometrium, adenocarcinoma cell line, uterus .b 488 to 1184 690 to 1   available from MGC, Submitted on the opposite strand 690/699
(98 %)
17 diff
(97.6 %id)
NM_006807.4   .b 772 to 3192 1 to 2421 exact RefSeq, AAA   2421/2421
(100 %)
0 diff
(100 %id)
DA689514   .b 773 to 1316 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA382816 thalamus .b 785 to 1413 2 to 630   capped   629/629
(100 %)
1 diff
(99.9 %id)
DB245554 uterus, tumor tissue .b 932 to 1497 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA781730 brain .b 958 to 1516 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA349601 substantia nigra .b 962 to 1517 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB019055 esophageal, tumor tissue .b 962 to 1537 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BI085440 astrocytoma grade IV, cell line, brain .b 970 to 1562 1 to 593       593/593
(100 %)
17 diff
(97.2 %id)
BM019450 astrocytoma grade IV, cell line, brain .b 970 to 1540 1 to 584       557/587
(94 %)
21 diff
(96.5 %id)
BC021302 Brain, astrocytoma, grade IV .b 971 to 3184 1 to 2214 exact tiling clone, available from MGC, AAA   2214/2214
(100 %)
1 diff
(100.0 %id)
BM549170 astrocytoma grade IV, cell line, brain .b 972 to 2043 1 to 1084 K150X A152S N153H V159G E165X ...     1084/1120
(96 %)
37 diff
(96.7 %id)
BM909685 astrocytoma grade IV, cell line, brain .b 973 to 1550 1 to 579       579/1047
(55 %)
5 diff
(99.6 %id)
DA140930 alzheimer cortex .b 1066 to 1701 2 to 638   capped   637/637
(100 %)
1 diff
(99.9 %id)
DA747006   .b 1069 to 1631 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DB052043 testis .b 1086 to 1652 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
NM_001127228.1   .c 1 to 2230 2 to 2231   RefSeq, AAA   2231/2231
(100 %)
0 diff
(100 %id)
DA020204   .c 1 to 563 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
DA002729   .c 28 to 594 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB046991 testis .c 28 to 581 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BU566458 mixed (pool of 40 RNAs) .c 31 to 344 1 to 315       315/940
(33 %)
9 diff
(99.1 %id)
CT004934 T-Lymphocytes .c 54 to 970 1 to 917       917/918
(99 %)
4 diff
(99.6 %id)
DA152619 amygdala .c 60 to 615 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AK312615 brain .c 61 to 848 1 to 788       788/788
(100 %)
1 diff
(99.9 %id)
DA298593 hippocampus .c 62 to 631 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA578530   .c 62 to 612 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BM452115 melanotic melanoma, skin .c 67 to 868 32 to 840 K8N K9E K104I S129R L135P ...     811/1119
(72 %)
40 diff
(96.5 %id)
DA258134 caudate nucleus .c 69 to 635 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BG394156 eye, retinoblastoma .c 73 to 597 1 to 525       525/561
(93 %)
5 diff
(99.2 %id)
U35451   .c 75 to 2222 1 to 2148       2148/2148
(100 %)
12 diff
(99.5 %id)
BC002609 Ovary, adenocarcinoma .c 76 to 2230 1 to 2155   tiling clone, available from MGC, AAA   2155/2155
(100 %)
2 diff
(100.0 %id)
BE315541 adenocarcinoma cell line, ovary .c 76 to 946 13 to 893 F113L A114L R115E G116V L117W ...     881/963
(91 %)
44 diff
(95.5 %id)
DA997544   .c 77 to 378 2 to 303   capped   302/302
(100 %)
0 diff
(100 %id)
AL558607 T cells from T cell leukemia .c 79 to 1030 1 to 952       952/952
(100 %)
8 diff
(99.2 %id)
DA484946 brain .c 79 to 657 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA575975   .c 80 to 634 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BQ956491 large cell carcinoma, lung .c 80 to 1023 1 to 953       953/953
(100 %)
11 diff
(98.9 %id)
DA603596   .c 80 to 869 2 to 796 E143X V154C K155Q C156V Q158T ... capped   795/796
(99 %)
13 diff
(98.4 %id)
DB026977 testis .c 80 to 640 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BU517067 leiomyosarcoma, uterus .c 85 to 898 1 to 816       816/862
(94 %)
5 diff
(99.5 %id)
DA574623   .c 88 to 670 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
BX442555 brain, fetal brain .c 89 to 1158 1 to 1053 L14I E37X L40K W42*     1054/1059
(99 %)
34 diff
(96.8 %id)
BX364573 Neuroblastoma Cot 25-normalized .c 90 to 925 1 to 833 E131X E151X A152S N153Q V154C ...     833/833
(100 %)
7 diff
(99.2 %id)
BG119144 adenocarcinoma, cell line, Liver .c 90 to 791 1 to 701       701/702
(99 %)
16 diff
(97.8 %id)
BQ961480 leiomyosarcoma, uterus .c 96 to 849 1 to 764 N140T S141L D142M E143R A144L ...     764/970
(78 %)
16 diff
(98.4 %id)
BQ062483 lymph, lymphoma, cell line .c 97 to 974 1 to 888 K180Q     888/993
(89 %)
14 diff
(98.6 %id)
BQ064273 lymph, lymphoma, cell line .c 97 to 1012 1 to 925       925/987
(93 %)
19 diff
(98.1 %id)
BQ066418 lymph, lymphoma, cell line .c 97 to 1061 1 to 980 K184X     980/996
(98 %)
30 diff
(97.0 %id)
DA656566   .c 100 to 672 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
CN409650 embryonic stem cells, DMSO-treated H9 cellline .c 106 to 812 1 to 707       707/707
(100 %)
5 diff
(99.3 %id)
BP277815   .c 118 to 699 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA747491   .c 132 to 699 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
TI_59381410   .c 138 to 903 99 to 870 D28E V36R E37G Y38V L39P ...     774/774
(100 %)
31 diff
(96.0 %id)
BQ070947 brain, neuroblastoma, cell line .c 139 to 931 1 to 809 G2A K150Q E151G A152T F163L ...     809/1020
(79 %)
34 diff
(96.7 %id)
BQ428070 melanotic melanoma, skin .c 153 to 1023 4 to 885 E165X K184Q     882/897
(98 %)
29 diff
(96.8 %id)
DA752496   .c 186 to 760 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB124155 thymus .c 186 to 763 2 to 579   tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
BE718811 head_neck .c 231 to 580 365 to 16       350/365
(95 %)
0 diff
(100 %id)
BE772613 prostate_tumor .c 231 to 572 342 to 2       341/342
(99 %)
0 diff
(100 %id)
BE772615 prostate_tumor .c 231 to 580 364 to 15       350/364
(96 %)
0 diff
(100 %id)
BE772732 prostate_tumor .c 231 to 573 343 to 1       343/343
(100 %)
0 diff
(100 %id)
BE772734 prostate_tumor .c 231 to 573 343 to 1       343/343
(100 %)
0 diff
(100 %id)
BE772735 prostate_tumor .c 231 to 571 341 to 1       341/341
(100 %)
7 diff
(98.0 %id)
BE772742 prostate_tumor .c 231 to 573 343 to 1       343/343
(100 %)
0 diff
(100 %id)
BE772747 prostate_tumor .c 231 to 586 372 to 17       356/372
(95 %)
0 diff
(100 %id)
BE772748 prostate_tumor .c 231 to 580 368 to 19       350/368
(95 %)
0 diff
(100 %id)
BE772751 prostate_tumor .c 231 to 573 343 to 1       343/343
(100 %)
0 diff
(100 %id)
BE773206 prostate_tumor .c 231 to 580 366 to 17       350/366
(95 %)
0 diff
(100 %id)
BE810309 pnet .c 231 to 578 359 to 13       347/359
(96 %)
0 diff
(100 %id)
BE810310 pnet .c 231 to 586 360 to 5       356/360
(98 %)
0 diff
(100 %id)
BE810311 pnet .c 231 to 573 343 to 1       343/343
(100 %)
0 diff
(100 %id)
BE810320 pnet .c 231 to 573 1 to 343       343/343
(100 %)
0 diff
(100 %id)
BE810322 pnet .c 231 to 573 1 to 343       343/343
(100 %)
0 diff
(100 %id)
BE810326 pnet .c 231 to 573 343 to 1       343/343
(100 %)
1 diff
(99.8 %id)
BE810327 pnet .c 231 to 580 373 to 24       350/373
(93 %)
0 diff
(100 %id)
BU190803 melanotic melanoma, cell line, skin .c 232 to 1023 1 to 807 K180X     807/921
(87 %)
29 diff
(96.9 %id)
BF090223 nervous_normal .c 250 to 365 1 to 115       115/115
(100 %)
6 diff
(94.8 %id)
BE701364 nervous_normal .c 252 to 580 344 to 24       321/365
(87 %)
1 diff
(99.8 %id)
BE718796 head_neck .c 252 to 580 343 to 15       329/364
(90 %)
1 diff
(99.8 %id)
BE718801 head_neck .c 252 to 580 344 to 16       329/365
(90 %)
1 diff
(99.8 %id)
BE718807 head_neck .c 252 to 580 341 to 14       328/362
(90 %)
1 diff
(99.8 %id)
BE718814 head_neck .c 252 to 580 345 to 17       329/363
(90 %)
2 diff
(99.5 %id)
BE772622 prostate_tumor .c 252 to 573 322 to 1       322/343
(93 %)
2 diff
(99.5 %id)
BE772744 prostate_tumor .c 252 to 573 322 to 1       322/343
(93 %)
2 diff
(99.5 %id)
BE832078 marrow .c 252 to 573 322 to 1       322/343
(93 %)
4 diff
(98.9 %id)
BE733279 choriocarcinoma, placenta .c 271 to 598 1 to 328       328/328
(100 %)
0 diff
(100 %id)
BE731753 choriocarcinoma, placenta .c 272 to 598 1 to 327       327/327
(100 %)
0 diff
(100 %id)
CR456766   .c 291 to 848 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
AA081081   .c 292 to 862 1 to 577     Submitted on the opposite strand 577/577
(100 %)
17 diff
(97.1 %id)
BQ069159 brain, neuroblastoma, cell line .c 302 to 1249 1 to 961       961/1012
(94 %)
21 diff
(98.0 %id)
BE772621 prostate_tumor .c 304 to 570 268 to 3       266/268
(99 %)
2 diff
(99.3 %id)
BE742645 adenocarcinoma cell line, ovary .c 308 to 598 1 to 291       291/291
(100 %)
0 diff
(100 %id)
BE718808 head_neck .c 369 to 573 205 to 1       205/205
(100 %)
0 diff
(100 %id)
TI_59380474   .c 376 to 906 56 to 587       532/532
(100 %)
2 diff
(99.7 %id)
AW948648 prostate_tumor .c 382 to 799 423 to 6     Submitted on the opposite strand 418/423
(98 %)
0 diff
(100 %id)
BM012423 brain, neuroblastoma, cell line .c 402 to 1210 1 to 812       812/813
(99 %)
16 diff
(98.1 %id)
TI_59380464   .c 403 to 1040 63 to 706       644/644
(100 %)
15 diff
(97.7 %id)
TI_59380539   .c 403 to 904 64 to 565       502/502
(100 %)
1 diff
(99.9 %id)
TI_59380610   .c 403 to 1143 63 to 802       740/740
(100 %)
8 diff
(99.0 %id)
TI_59381574   .c 403 to 948 107 to 658       552/552
(100 %)
9 diff
(98.4 %id)
TI_59381635   .c 403 to 1210 98 to 908       811/812
(99 %)
15 diff
(98.2 %id)
BU942656 mixed (pool of 40 RNAs) .c 440 to 1136 1 to 705   AAA   705/733
(96 %)
13 diff
(98.3 %id)
CX866116 embryonic stem .c 454 to 1189 1 to 736       736/736
(100 %)
0 diff
(100 %id)
CN409655 embryonic stem cells, DMSO-treated H9 cellline .c 508 to 788 1 to 281       281/281
(100 %)
0 diff
(100 %id)
BP275921 Kidney .c 520 to 1081 1 to 562       562/562
(100 %)
0 diff
(100 %id)
BF925431 nervous_tumor .c 543 to 760 227 to 11     Submitted on the opposite strand 217/227
(95 %)
0 diff
(100 %id)
BE540426 cervix .c 553 to 1238 1 to 689       689/881
(78 %)
13 diff
(98.6 %id)
BG250680 adenocarcinoma, cell line, Liver .c 624 to 1302 1 to 680       680/1109
(61 %)
11 diff
(99.1 %id)
CN409649 embryonic stem cells, DMSO-treated H9 cellline .c 633 to 1235 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BM019678 astrocytoma grade IV, cell line, brain .c 749 to 1536 1 to 787       787/787
(100 %)
29 diff
(96.4 %id)
TI_59389669   .c 750 to 1213 63 to 528       466/466
(100 %)
13 diff
(97.3 %id)
TI_59390371   .c 750 to 1536 131 to 916       786/786
(100 %)
28 diff
(96.5 %id)
AA081080   .c 865 to 1257 397 to 1     Submitted on the opposite strand 397/400
(99 %)
5 diff
(98.8 %id)
CR617932 HeLa cells Cot 25-normalized .c 1006 to 2224 1 to 1219   tiling clone,   1219/1219
(100 %)
0 diff
(100 %id)
BX384121   .c 1006 to 1936 1 to 932       932/939
(99 %)
8 diff
(99.2 %id)
AI969164 brain, four pooled pituitary adenomas .c 1028 to 1429 402 to 1       402/402
(100 %)
0 diff
(100 %id)
BF930060 nervous_tumor .c 1029 to 1468 447 to 11     Submitted on the opposite strand 437/462
(94 %)
0 diff
(100 %id)
BG675118 skin .c 1032 to 2031 1 to 994       994/1003
(99 %)
37 diff
(96.4 %id)
BE084626 breast .c 1039 to 1258 221 to 2     Submitted on the opposite strand 220/432
(50 %)
0 diff
(100 %id)
BX384120   .c 1187 to 2185 996 to 1       996/997
(99 %)
18 diff
(98.2 %id)
BF971972 leiomyosarcoma cell line, uterus .c 1190 to 1991 1 to 797       797/929
(85 %)
26 diff
(97.3 %id)
CR611707 Neuroblastoma Cot 10-normalized .c 1205 to 2203 1 to 999       999/999
(100 %)
0 diff
(100 %id)
AL520402 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 1205 to 2229 1 to 1024   fully sequenced,   1024/1024
(100 %)
14 diff
(98.7 %id)
AL580389 T cells from T cell leukemia .c 1229 to 2197 967 to 1       967/968
(99 %)
13 diff
(98.7 %id)
AL520401 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 1262 to 2203 944 to 1   fully sequenced,   944/944
(100 %)
8 diff
(99.2 %id)
BM990599 lung, Lung Focal Fibrosis .c 1295 to 1930 96 to 731     Submitted on the opposite strand 636/731
(87 %)
9 diff
(98.8 %id)
BU950954 Pancreas, Purified pancreatic islet .c 1301 to 1879 1 to 579   fully sequenced,   579/579
(100 %)
0 diff
(100 %id)
BX110842 liver and spleen .c 1307 to 1979 1 to 673       673/673
(100 %)
1 diff
(99.9 %id)
CN409666 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1309 to 1972 8 to 671       664/671
(98 %)
6 diff
(99.2 %id)
CB157890 Liver .c 1309 to 1748 1 to 440       440/440
(100 %)
0 diff
(100 %id)
CN409653 embryonic stem cells, DMSO-treated H9 cellline .c 1311 to 2063 1 to 749       749/749
(100 %)
7 diff
(99.1 %id)
BG822030 adenocarcinoma cell line, colon .c 1311 to 2098 1 to 787       787/787
(100 %)
2 diff
(99.8 %id)
CB143674 Liver .c 1311 to 1735 1 to 425       425/425
(100 %)
0 diff
(100 %id)
CN409657 embryonic stem cells, DMSO-treated H9 cellline .c 1313 to 1948 1 to 636       636/636
(100 %)
0 diff
(100 %id)
CN409648 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1315 to 2064 1 to 750       750/750
(100 %)
1 diff
(99.9 %id)
CN409668 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1316 to 1974 8 to 667       660/667
(98 %)
6 diff
(99.2 %id)
W38873 parathyroid gland, parathyroid tumor .c 1317 to 1692 1 to 376       376/377
(99 %)
1 diff
(99.8 %id)
CB143482 Liver .c 1317 to 1752 1 to 436       436/436
(100 %)
0 diff
(100 %id)
W60642 heart .c 1320 to 1988 1 to 670       670/679
(98 %)
16 diff
(97.7 %id)
BU553759 ovary, teratocarcinoma, cell line .c 1322 to 2223 1 to 906       906/906
(100 %)
13 diff
(98.6 %id)
BU553842 ovary, teratocarcinoma, cell line .c 1322 to 2222 1 to 902   AAA   902/902
(100 %)
3 diff
(99.7 %id)
BF036365 adenocarcinoma, ovary .c 1324 to 2109 1 to 790       790/968
(81 %)
20 diff
(98.0 %id)
BU845540 ovary, teratocarcinoma, cell line .c 1324 to 2143 1 to 829       829/897
(92 %)
11 diff
(98.8 %id)
T19927   .c 1325 to 1554 230 to 1       230/230
(100 %)
2 diff
(99.2 %id)
AA432241   .c 1325 to 1738 1 to 413       413/413
(100 %)
2 diff
(99.6 %id)
BM710791 eye, fetal eyes .c 1325 to 1641 1 to 317       317/317
(100 %)
1 diff
(99.7 %id)
BU944636 adenocarcinoma, cell line, breast .c 1327 to 2222 1 to 898   AAA   898/898
(100 %)
5 diff
(99.5 %id)
AW378519 head_neck .c 1328 to 1945 660 to 45       616/661
(93 %)
0 diff
(100 %id)
CN409664 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1328 to 1926 1 to 599       599/599
(100 %)
0 diff
(100 %id)
CB157802 Liver .c 1329 to 1748 1 to 420       420/420
(100 %)
0 diff
(100 %id)
BM700375 eye, lens .c 1329 to 1641 1 to 313       313/313
(100 %)
0 diff
(100 %id)
BG249202 hypernephroma, cell line, Kidney .c 1331 to 2081 1 to 746       746/945
(78 %)
9 diff
(99.1 %id)
BQ071303 brain, neuroblastoma, cell line .c 1332 to 2101 1 to 775       775/1030
(75 %)
21 diff
(98.0 %id)
BF038523 adenocarcinoma, ovary .c 1337 to 2100 1 to 748       748/896
(83 %)
15 diff
(98.4 %id)
BG329279 eye, retinoblastoma .c 1337 to 2078 1 to 741       741/741
(100 %)
5 diff
(99.4 %id)
BM700908 eye, human retina .c 1338 to 1755 1 to 418   fully sequenced,   418/418
(100 %)
6 diff
(98.6 %id)
BX364572 Neuroblastoma Cot 25-normalized .c 1342 to 2171 830 to 1       830/830
(100 %)
2 diff
(99.8 %id)
AA448093   .c 1343 to 1776 1 to 435       435/435
(100 %)
2 diff
(99.6 %id)
TI_149300642   .c 1343 to 2222 942 to 80   AAA   863/984
(87 %)
33 diff
(96.7 %id)
CN409669 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1344 to 1850 1 to 507       507/507
(100 %)
0 diff
(100 %id)
BQ922545 epidermoid carcinoma, cell line, lung .c 1349 to 2222 1 to 881   AAA   881/881
(100 %)
12 diff
(98.7 %id)
D79222 aorta .c 1354 to 1554 1 to 201       201/201
(100 %)
0 diff
(100 %id)
BE253970 eye, retinoblastoma .c 1357 to 2166 1 to 804       804/878
(91 %)
19 diff
(97.9 %id)
BE253969 eye, retinoblastoma .c 1359 to 2209 1 to 847       847/855
(99 %)
27 diff
(96.9 %id)
TI_154124011   .c 1361 to 2222 955 to 97   AAA   859/1024
(83 %)
17 diff
(98.4 %id)
TI_154103544   .c 1366 to 2230 947 to 88   AAA   860/1000
(86 %)
13 diff
(98.7 %id)
TI_149294547   .c 1370 to 2222 933 to 85   AAA   849/979
(86 %)
15 diff
(98.5 %id)
BM698727 eye, fetal eyes .c 1370 to 1846 1 to 477   fully sequenced,   477/477
(100 %)
1 diff
(99.8 %id)
T35919 blood, white blood cells .c 1373 to 1667 1 to 295       295/295
(100 %)
0 diff
(100 %id)
TI_149309673   .c 1373 to 2222 932 to 87   AAA   846/952
(88 %)
35 diff
(96.4 %id)
BM726192 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1373 to 1734 1 to 362   fully sequenced,   362/362
(100 %)
0 diff
(100 %id)
TI_151771164   .c 1378 to 2087 108 to 819       712/824
(86 %)
15 diff
(98.2 %id)
BE891601 melanotic melanoma, skin .c 1385 to 2129 1 to 739       739/905
(81 %)
15 diff
(98.4 %id)
TI_149310582   .c 1387 to 2222 915 to 84   AAA   832/973
(85 %)
47 diff
(95.2 %id)
BX413704 brain, fetal brain .c 1388 to 2209 829 to 4       826/911
(90 %)
0 diff
(100 %id)
BF032914 adenocarcinoma, ovary .c 1398 to 2179 1 to 783       783/873
(89 %)
25 diff
(97.2 %id)
BG756491 B-cells, primary B-cells from tonsils (cell line) .c 1405 to 2231 1 to 827       827/835
(99 %)
9 diff
(99.0 %id)
AA034453 heart .c 1412 to 1830 1 to 422   fully sequenced,   422/422
(100 %)
4 diff
(99.1 %id)
AA165072   .c 1412 to 1862 1 to 452   fully sequenced,   452/452
(100 %)
2 diff
(99.6 %id)
BM449915 melanotic melanoma, skin .c 1413 to 2222 1 to 811   AAA   811/811
(100 %)
5 diff
(99.4 %id)
TI_154037477   .c 1417 to 2222 889 to 92   AAA   798/934
(85 %)
13 diff
(98.7 %id)
TI_154002015   .c 1418 to 2222 877 to 83   AAA   795/903
(88 %)
15 diff
(98.4 %id)
TI_154011298   .c 1418 to 2222 884 to 105   AAA   780/1218
(64 %)
60 diff
(95.1 %id)
TI_154049477   .c 1434 to 2222 875 to 88   AAA   788/973
(80 %)
13 diff
(98.7 %id)
BU600062 mixed (pool of 40 RNAs) .c 1435 to 2185 1 to 759       759/764
(99 %)
12 diff
(98.5 %id)
CN409671 embryonic stem cells, DMSO-treated H9 cellline .c 1441 to 2150 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
BU621178 cell lines, Chondrosarcoma .c 1452 to 2222 788 to 19   AAA   770/770
(100 %)
3 diff
(99.7 %id)
AA084042   .c 1455 to 1811 1 to 359   fully sequenced,   359/359
(100 %)
2 diff
(99.5 %id)
BU170858 eye, retinoblastoma .c 1456 to 2222 1 to 774       774/778
(99 %)
13 diff
(98.4 %id)
BG402792 bladder, transitional cell papilloma, cell line .c 1460 to 2152 112 to 813       702/1111
(63 %)
6 diff
(99.5 %id)
BQ574943 Chondrosarcoma Grade II, Left Pelvis .c 1460 to 2222 778 to 19   AAA   760/786
(96 %)
11 diff
(98.7 %id)
TI_149279177   .c 1469 to 2222 848 to 90   AAA   759/1154
(65 %)
29 diff
(97.5 %id)
TI_149310313   .c 1469 to 2222 846 to 94   AAA   753/896
(84 %)
8 diff
(99.2 %id)
TI_149312977   .c 1474 to 2222 826 to 86   AAA   741/929
(79 %)
22 diff
(97.7 %id)
TI_149307275   .c 1476 to 2222 834 to 91   AAA   744/952
(78 %)
12 diff
(98.8 %id)
W02965 melanocyte .c 1480 to 1880 1 to 398   fully sequenced,   398/398
(100 %)
10 diff
(97.5 %id)
N31342 melanocyte .c 1481 to 1774 1 to 297   fully sequenced,   297/297
(100 %)
2 diff
(99.4 %id)
TI_149298101   .c 1482 to 2222 805 to 78   AAA   728/950
(76 %)
39 diff
(95.9 %id)
BM696890 eye, lens .c 1482 to 1845 1 to 364   fully sequenced,   364/364
(100 %)
0 diff
(100 %id)
BU934964 mixed (pool of 40 RNAs) .c 1498 to 2228 1 to 733       733/797
(91 %)
11 diff
(98.7 %id)
CA430515 Cell Line, Chondrosarcoma .c 1501 to 2222 738 to 17   AAA   722/722
(100 %)
2 diff
(99.8 %id)
TI_149294083   .c 1505 to 2222 796 to 79   AAA   718/719
(99 %)
17 diff
(97.7 %id)
CA418843 Chondrosarcoma Grade II, Left Pelvis .c 1511 to 2222 729 to 19   AAA   711/718
(99 %)
4 diff
(99.5 %id)
BU607661 Human Lung Epithelial cells, lung .c 1512 to 2222 727 to 17   AAA   711/711
(100 %)
1 diff
(99.9 %id)
BQ773915 Chondrosarcoma Grade II, Left Pelvis .c 1512 to 2222 728 to 19   AAA   710/710
(100 %)
3 diff
(99.6 %id)
BU634042 cell lines, Chondrosarcoma .c 1526 to 2222 715 to 19   AAA   697/697
(100 %)
1 diff
(99.9 %id)
CA444481 Fibrosarcoma .c 1528 to 2222 713 to 19   AAA   695/695
(100 %)
1 diff
(99.9 %id)
BQ775809 Bone, Human Chondrosarcoma Cell Line .c 1528 to 2222 712 to 17   AAA   696/696
(100 %)
2 diff
(99.8 %id)
BM985071 lung .c 1529 to 2222 710 to 17   AAA   694/694
(100 %)
1 diff
(99.9 %id)
CK725198 Chondrosarcoma, Left Pubic Bone .c 1529 to 2230 717 to 19   AAA   699/699
(100 %)
1 diff
(99.9 %id)
CB053834.
matches multiple genes
leiomyosarcoma, soft tissue .c 1547 to 2222 701 to 26   AAA also hits gene CBX1P2 676/676
(100 %)
0 diff
(100 %id)
BQ021557 lung, Metastatic Chondrosarcoma .c 1547 to 2230 702 to 19   AAA   684/684
(100 %)
2 diff
(99.8 %id)
W79251 heart .c 1549 to 1882 1 to 334   fully sequenced,   334/334
(100 %)
4 diff
(98.9 %id)
BU618744 Cell Line, Chondrosarcoma .c 1550 to 2222 690 to 19   AAA   672/672
(100 %)
3 diff
(99.6 %id)
TI_154094478   .c 1551 to 2222 788 to 117   AAA   672/672
(100 %)
5 diff
(99.3 %id)
BI492019 cochlea, ear .c 1553 to 2224 675 to 4       672/675
(99 %)
0 diff
(100 %id)
BI492161 cochlea, ear .c 1553 to 2222 688 to 19   AAA   670/670
(100 %)
1 diff
(99.9 %id)
BU734071 eye, Retina Foveal and Macular .c 1554 to 2222 685 to 17   AAA   669/669
(100 %)
1 diff
(99.9 %id)
BM126979 Islets of Langerhans, Pancreas .c 1556 to 1902 1 to 347   fully sequenced,   347/347
(100 %)
1 diff
(99.8 %id)
CB135342 Liver .c 1566 to 2100 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BU686692 lung, Primary Lung Epithelial Cells .c 1576 to 2222 663 to 17   AAA   647/647
(100 %)
0 diff
(100 %id)
AA046851 heart .c 1578 to 2202 1 to 619   fully sequenced,   619/619
(100 %)
13 diff
(97.9 %id)
TI_151717242   .c 1579 to 2226 778 to 136   AAA   643/705
(91 %)
19 diff
(97.4 %id)
EL949559 eyeball .c 1581 to 2115 1 to 535       535/535
(100 %)
6 diff
(98.9 %id)
BM876184 insulinoma, Pancreas .c 1593 to 2163 16 to 586   AAA Submitted on the opposite strand 571/586
(97 %)
8 diff
(98.7 %id)
CK824033 insulinoma, Pancreas .c 1593 to 2066 16 to 489   AAA Submitted on the opposite strand 474/489
(96 %)
6 diff
(98.8 %id)
BM847569 myeloma .c 1593 to 1793 201 to 1   AAA Submitted on the opposite strand 201/289
(69 %)
1 diff
(99.7 %id)
BU625204 cell lines, Enchondroma .c 1614 to 2222 627 to 19   AAA   609/618
(98 %)
0 diff
(100 %id)
W74445 heart .c 1629 to 2222 589 to 1       589/589
(100 %)
10 diff
(98.4 %id)
BI711474 insulinoma, Pancreas .c 1664 to 2228 580 to 16   AAA   565/565
(100 %)
1 diff
(99.9 %id)
BM680811 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1704 to 2230 545 to 19   fully sequenced, AAA   527/527
(100 %)
0 diff
(100 %id)
EB362220 eye, lens .c 1709 to 2089 378 to 1       378/379
(99 %)
1 diff
(99.8 %id)
BE223018 brain, oligodendroglioma .c 1709 to 2224 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AW970428   .c 1715 to 2221 507 to 1     Submitted on the opposite strand 507/605
(83 %)
6 diff
(99.1 %id)
BM667613 eye, fetal eyes .c 1732 to 2222 509 to 19   AAA   491/491
(100 %)
1 diff
(99.8 %id)
BQ003274 Chondrosarcoma, Left Pelvis .c 1733 to 2222 506 to 17   AAA   490/490
(100 %)
0 diff
(100 %id)
AI363231 brain, glioblastoma (pooled) .c 1734 to 2230 497 to 1       497/497
(100 %)
0 diff
(100 %id)
BE223025 brain, oligodendroglioma .c 1740 to 2224 485 to 1       485/485
(100 %)
0 diff
(100 %id)
N21387 melanocyte .c 1744 to 2222 484 to 1   fully sequenced,   484/484
(100 %)
4 diff
(99.2 %id)
BM672252 eye, human retina .c 1746 to 2222 495 to 19   fully sequenced, AAA   477/477
(100 %)
2 diff
(99.6 %id)
W42825 senescent fibroblast .c 1759 to 2208 9 to 462   fully sequenced,   454/462
(98 %)
6 diff
(98.8 %id)
TI_149275448   .c 1761 to 2222 546 to 85   AAA   462/718
(64 %)
2 diff
(99.8 %id)
AA872922 2 pooled tumors (clear cell type), Kidney .c 1766 to 2222 475 to 19   AAA   457/457
(100 %)
0 diff
(100 %id)
AI140728 parathyroid gland, parathyroid tumor .c 1773 to 2096 324 to 1       324/324
(100 %)
0 diff
(100 %id)
FN070221 breast carcinoma .c 1774 to 1856 1 to 83       83/84
(98 %)
1 diff
(98.9 %id)
AI199442 anaplastic oligodendroglioma, brain .c 1775 to 2224 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AW273464 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1776 to 2222 447 to 1       447/447
(100 %)
0 diff
(100 %id)
AI610793 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1777 to 2222 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AA112180   .c 1781 to 2221 441 to 1   fully sequenced,   441/441
(100 %)
0 diff
(100 %id)
BU684554 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1785 to 2222 454 to 17   AAA   438/438
(100 %)
0 diff
(100 %id)
BM673545 eye, human retina .c 1785 to 2222 456 to 19   AAA   438/438
(100 %)
2 diff
(99.6 %id)
N92595 parathyroid gland, parathyroid tumor .c 1787 to 2224 440 to 4       437/442
(98 %)
0 diff
(100 %id)
AW769024 colon, moderately-differentiated adenocarcinoma .c 1795 to 2222 428 to 1       428/428
(100 %)
0 diff
(100 %id)
AA614830 breast .c 1796 to 2221 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AI370840   .c 1797 to 2222 436 to 11   AAA   426/426
(100 %)
0 diff
(100 %id)
AA053964 heart .c 1800 to 2222 425 to 1   fully sequenced,   425/425
(100 %)
2 diff
(99.6 %id)
AA987945 carcinoid, lung .c 1800 to 2223 424 to 1       424/424
(100 %)
0 diff
(100 %id)
AI299990 carcinoid, lung .c 1815 to 2230 430 to 15   AAA   416/416
(100 %)
0 diff
(100 %id)
BU735476 eye, lens .c 1815 to 2228 421 to 13   fully sequenced,   409/421
(97 %)
5 diff
(98.9 %id)
BU737173 eye, fetal eyes .c 1816 to 2222 424 to 18   fully sequenced, AAA   407/407
(100 %)
0 diff
(100 %id)
AA447594   .c 1818 to 2222 405 to 1       405/405
(100 %)
0 diff
(100 %id)
BX369684   .c 1823 to 2224 1 to 402       402/402
(100 %)
1 diff
(99.8 %id)
W61216 heart .c 1823 to 2222 1 to 400   fully sequenced,   400/400
(100 %)
3 diff
(99.3 %id)
AA164675   .c 1832 to 2221 390 to 1   fully sequenced,   390/390
(100 %)
2 diff
(99.5 %id)
AA988657 carcinoid, lung .c 1839 to 2224 386 to 1       386/386
(100 %)
0 diff
(100 %id)
BU952401 Pancreas, Purified pancreatic islet .c 1849 to 2227 379 to 1   fully sequenced,   379/379
(100 %)
3 diff
(99.3 %id)
N73001 melanocyte .c 1850 to 2222 373 to 1   fully sequenced,   373/373
(100 %)
0 diff
(100 %id)
W73919 heart .c 1852 to 2222 372 to 1   fully sequenced,   372/372
(100 %)
3 diff
(99.2 %id)
W60969 heart .c 1861 to 2226 374 to 1   fully sequenced,   374/374
(100 %)
5 diff
(98.7 %id)
BE676794 B-cell, chronic lymphotic leukemia .c 1861 to 2223 363 to 1       363/363
(100 %)
0 diff
(100 %id)
BQ011718 placenta .c 1862 to 2220 377 to 19   AAA   359/359
(100 %)
0 diff
(100 %id)
AI359573 brain, glioblastoma (pooled) .c 1865 to 2230 366 to 1       366/367
(99 %)
0 diff
(100 %id)
AI185431 lung .c 1871 to 2224 354 to 1       354/354
(100 %)
0 diff
(100 %id)
BM126689 Islets of Langerhans, Pancreas .c 1872 to 2224 353 to 1   fully sequenced,   353/353
(100 %)
0 diff
(100 %id)
AA910970 pooled germ cell tumors .c 1875 to 2222 348 to 1       348/348
(100 %)
0 diff
(100 %id)
AA814435 germinal center B cell .c 1878 to 2222 356 to 12   AAA   345/345
(100 %)
0 diff
(100 %id)
AA428625   .c 1888 to 2226 343 to 5       339/343
(98 %)
0 diff
(100 %id)
AI081602 liver and spleen .c 1898 to 2223 326 to 1       326/326
(100 %)
0 diff
(100 %id)
AA832516 carcinoid, lung .c 1899 to 2223 325 to 1       325/325
(100 %)
0 diff
(100 %id)
BY999308   .c 1909 to 2224 1 to 316     Submitted on the opposite strand 316/317
(99 %)
1 diff
(99.7 %id)
W42735 senescent fibroblast .c 1910 to 2222 313 to 1   fully sequenced,   313/313
(100 %)
0 diff
(100 %id)
AA771867 parathyroid gland, parathyroid tumor .c 1937 to 2222 297 to 12   AAA   286/286
(100 %)
0 diff
(100 %id)
BM126009 Islets of Langerhans, Pancreas .c 1948 to 2224 277 to 1       277/277
(100 %)
1 diff
(99.7 %id)
AA513283 breast .c 1957 to 2229 273 to 1       273/273
(100 %)
0 diff
(100 %id)
AI263947 adenocarcinoma, colon .c 1959 to 2222 264 to 1       264/264
(100 %)
0 diff
(100 %id)
AA046813 heart .c 1965 to 2223 259 to 1   fully sequenced,   259/259
(100 %)
0 diff
(100 %id)
T89291 liver and spleen .c 1966 to 2206 243 to 3       241/243
(99 %)
0 diff
(100 %id)
BE006752 breast_normal .c 1967 to 2187 244 to 24     Submitted on the opposite strand 221/287
(77 %)
0 diff
(100 %id)
BE006753 breast_normal .c 1967 to 2187 221 to 2     Submitted on the opposite strand 220/264
(83 %)
0 diff
(100 %id)
BE006757 breast_normal .c 1967 to 2187 222 to 2     Submitted on the opposite strand 221/265
(83 %)
0 diff
(100 %id)
TI_149291205   .c 2001 to 2222 309 to 84   AAA   226/234
(96 %)
5 diff
(97.9 %id)
CX866035 embryonic stem .c 2008 to 2222 243 to 29   AAA   215/215
(100 %)
3 diff
(98.7 %id)
AI918255 anaplastic oligodendroglioma, brain .c 2014 to 2222 209 to 1       209/209
(100 %)
0 diff
(100 %id)
AA136464.
matches multiple genes
lung, lung carcinoma .c 2029 to 2222 194 to 1     Submitted on the opposite strand, also hits gene peeser 194/194
(100 %)
0 diff
(100 %id)
AW264813 lung, two pooled squamous cell carcinomas .c 2103 to 2223 121 to 1       121/121
(100 %)
0 diff
(100 %id)
DR760359 embryonic stem .d 1 to 822 1 to 822 exact tiling clone,   822/822
(100 %)
4 diff
(99.6 %id)
DB270616 uterus .e 1 to 525 2 to 526 exact tiling clone, capped   525/525
(100 %)
2 diff
(99.7 %id)
DB116505 thymus .e 28 to 576 2 to 550 exact tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
BP260537 small intestine .f 1 to 583 2 to 584   tiling clone,   584/584
(100 %)
1 diff
(99.9 %id)
DA264346 caudate nucleus .f 3 to 575 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
DA683766   .f 8 to 499 2 to 493   capped   492/492
(100 %)
2 diff
(99.6 %id)
DB019359 esophageal, tumor tissue .g 1 to 549 2 to 550 exact tiling clone, capped   549/549
(100 %)
2 diff
(99.7 %id)
BP341663 stomach mucosa .h 1 to 577 5 to 581 S38G R60S tiling clone,   581/582
(99 %)
6 diff
(99.0 %id)
DA159489 amygdala .h 1 to 559 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA175257 amygdala .h 1 to 568 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DA966416 stomach .h 1 to 556 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BG898553 cartilage .h 12 to 545 72 to 605       534/548
(97 %)
6 diff
(99.0 %id)
BP195172 brain .h 18 to 551 1 to 534   tiling clone, AAA   534/534
(100 %)
1 diff
(99.9 %id)
DA574765   .h 22 to 570 2 to 550   capped   549/550
(99 %)
0 diff
(100 %id)
DB006429 cervix, tumor tissue .h 25 to 570 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
CB053835.
matches multiple genes
leiomyosarcoma, soft tissue P2.a-u 1 to 657 6 to 662 Y2C L3C V4S S5H Q6K ... tiling clone, also hits gene CBX1P2 657/664
(98 %)
20 diff
(97.0 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI